<p><em>Damien Leonard，Pinetree Capital Ltd.（多伦多证券交易所代码：PNP）总裁，将加入 TruBridge 董事会</em></p>
<p>阿拉巴马州莫比尔 --（商业资讯）--TruBridge, Inc.（“TruBridge” 或 “公司”）（纳斯达克代码：TBRG），一家医疗解决方案公司，今天宣布已同意延长与 Pinetree Capital Ltd.和 L6 Holdings Inc.（统称 “Pinetree”）的合作协议。Pinetree 是公司的最大股东。根据合作协议，TruBridge 将于 2026 年 1 月 12 日（在完成董事会成员的常规入职程序后）任命 Damien Leonard 为董事会成员（“董事会”）。</p>
<p>Leonard 先生预计将作为独立董事加入董事会，并将被任命为薪酬委员会成员。与此新增成员相关，董事会的规模将从九名董事增加到十名，其中八名为独立董事。除了 David Dye 之前宣布的在 2026 年股东年会上不再连任的意向（这将结束他在董事会的 24 年服务），还有两名额外董事将根据董事会的持续更新工作在 2026 年股东年会上不再连任。2026 年股东年会后，董事会的规模将为七名董事。</p>
<p>Leonard 先生是 Pinetree Capital Ltd.的总裁。他在加拿大、美国、欧洲和澳大利亚拥有超过十年的公共市场投资经验，专注于小型股和特殊情况投资，尤其是在企业软件和技术业务领域。</p>
<p>“我们很高兴欢迎 Damien 加入我们的董事会，” 董事会主席 Glenn Tobin 表示。“我们相信 Damien 的投资者视角以及他的金融、资本市场和资本配置经验，将对我们的董事会产生巨大价值。增加 Damien 继续推进董事会更新的进程，以支持我们的运营效率和长期战略。”</p>
<p>根据合作协议，另一名董事将在 2027 年股东年会上不再连任。此外，关于合作协议，Pinetree 已同意常规的停滞、投票和其他条款。Leonard 先生将放弃他在董事会服务期间的董事费用。</p>
<p>“我们很高兴与 Pinetree 达成建设性协议，” TruBridge 首席执行官 Chris Fowler 表示。“TruBridge 正在积累势头，这些举措将进一步增强我们执行增长战略的能力，取得良好成果。我们相信 Damien 将成为我们董事会的宝贵同事和成员，以及公司的投资者，因为我们将继续利用前方显著的机会，为所有股东创造可持续价值。”</p>
<p>与 Pinetree 的合作协议的完整文本将作为公司的当前报告的附件包含在 Form 8-K 中，该报告将提交给美国证券交易委员会。</p>
<p>BofA Securities, Inc.正在为公司提供股东参与方面的顾问服务，Sullivan &amp; Cromwell LLP 和 Maynard Nexsen PC 担任法律顾问。</p>
<p><strong>关于 TruBridge</strong></p>
<p>TruBridge 自豪地支持农村和社区医疗提供者，帮助他们在努力保持强大、独立和深深扎根于服务的社区中。凭借超过 45 年的医疗经验和全国超过 1,500 个客户的信任，TruBridge 提供一系列技术、服务和战略专业知识——包括收入周期管理（RCM）、电子健康记录（EHR）和分析——所有这些都是专门为农村和社区医疗的现实而设计。TruBridge 坚定承诺保持本地护理，帮助医院作为其社区的经济核心蓬勃发展，提供高质量、深具个人化的本地护理。</p>
<p><strong>前瞻性声明</strong></p>
<p>本新闻稿包含根据 1995 年《私人证券诉讼改革法案》“安全港” 条款的前瞻性声明。这些前瞻性声明通常可以通过使用前瞻性术语和词汇来识别，例如 “预计”、“预期”、“估计”、“相信”、“预测”、“打算”、“计划”、“潜在”、“可能”、“继续”、“应该”、“将” 和具有类似含义的词。为了不限制前述声明的一般性，本新闻稿中与公司最终任命 Leonard 先生为董事会成员、执行公司战略以及提升公司股东价值相关的所有声明均为前瞻性声明。我们提醒投资者，任何此类前瞻性声明仅为预测，并不保证未来的表现。某些风险、不确定性和其他因素可能导致实际结果与前瞻性声明中预测的结果存在重大差异。这些因素包括，关于最终任命 Leonard 先生为董事会成员，完成常规的入职程序；关于公司战略和提升价值，可能包括：我们目标市场的饱和和医院整合；不利的经济或市场条件可能导致信息技术和服务支出的下降；医疗行业的重大立法和监管不确定性；因未能遵守监管要求而面临的责任风险；向基于订阅的经常性收入模式的过渡和技术现代化；与财务、技术和市场资源比我们更强大的公司的竞争；潜在的未来收购可能成本高昂、耗时，并面临其他固有风险；我们在全球劳动力中吸引和留住合格人员的能力；由于销售团队的定期重组而造成的干扰；金融健康服务市场的发展速度低于预期；我们可能进入的新市场中有效管理增长的潜在失败；有效实施新的企业资源规划软件解决方案的潜在失败；通过我们的国内和国际业务活动面临众多且常常相互矛盾的法律、法规、政策、标准或其他要求的风险；针对我们的潜在诉讼和调查；我们使用离岸第三方资源的风险；与使用人工智能相关的竞争和诉讼风险；未能开发新产品或提升当前产品以跟上市场需求的潜在失败；我们的产品未能提供准确和及时的信息以支持临床决策；系统中的安全漏洞和病毒导致客户对我们的索赔和声誉受损；未能通过新产品发布保持客户满意度，且未发现错误或问题；未能说服客户迁移到当前或未来版本的产品；未能维持我们的利润率和服务费率；服务收入在总收入中所占比例增加，而服务收入的毛利率较低；在我们向支付方提供不准确的索赔数据时面临的责任风险；因软件许可和服务提供而产生的责任索赔风险；对第三方的权利、产品和服务的许可依赖；未能保护我们的知识产权；因知识产权侵权而面临的重大许可费用或损害赔偿；电力供应和/或电信能力中断的风险；在有利条件下无法获得额外融资以满足未来资本需求的潜在风险；我们巨额的债务，以及我们未来承担额外债务的能力；服务我们未偿债务的现金流压力；对我们当前和未来运营的信贷协议的限制条款；影响我们业绩测量的财务会计事项的变化和解释；如果我们的商誉或无形资产减值，将对收益产生重大影响；由于各种因素导致的季度财务表现波动；我们股票价格的波动；未能保持有效的财务报告内部控制；我们财务报告内部控制的固有限制；自然灾害造成的重大损害的脆弱性；与利率变化相关的市场风险；由于宏观经济条件可能导致的潜在重大不利影响；我们不预期向普通股支付股息；激进股东对我们的行动；以及不时在我们向证券交易委员会提交的公共发布和报告中描述的其他风险因素。我们还提醒投资者，此处描述的前瞻性信息仅代表我们截至本日期的展望，我们不承担更新或修订任何前瞻性声明以反映本新闻稿日期之后的事件或发展的义务。</p>
<p><img src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1hY3FyOCZzdHk9MjAyNjAxMDczNjQ0MDJyMQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1hY3FyOCZzdHk9MjAyNjAxMDczNjQ0MDJyMQ"/></p>
<p>在 businesswire.com 查看源版本：https://www.businesswire.com/news/home/20260107364402/en/</p>
<p>TruBridge Media</p>
<p>media@trubridge.com</p>
<p>来源：TruBridge, Inc.</p>

TBRG

<p>TruBridge, Inc. 已与 Pinetree Capital Ltd. 延长合作协议，任命 Pinetree 总裁 Damien Leonard 为董事会成员，自 2026 年 1 月 12 日生效。此次增补使董事会成员人数增加至十位，其中八位为独立董事。Leonard 还将加入薪酬委员会。董事会正在进行更新，三位董事在 2026 年年度会议上不寻求连任。TruBridge 旨在增强其增长战略，为股东创造可持续价值。BofA Securities 正在为公司提供股东互动方面的建议</p>

<p><em>Damien Leonard, President of Pinetree Capital Ltd. (TSX: PNP), to join the TruBridge Board of Directors</em></p>
<div class="lb-trans"><p><em>Damien Leonard，Pinetree Capital Ltd.（多伦多证券交易所代码：PNP）总裁，将加入 TruBridge 董事会</em></p>
</div><p>MOBILE, Ala.--(BUSINESS WIRE)--TruBridge, Inc. (“TruBridge” or the “Company”) (NASDAQ: TBRG), a healthcare solutions company, today announced that it has agreed to extend its cooperation agreement with Pinetree Capital Ltd. and L6 Holdings Inc. (together, “Pinetree”). Pinetree is the Company’s largest shareholder. Pursuant to the cooperation agreement, TruBridge will appoint Damien Leonard to its Board of Directors (the “Board”), effective January 12, 2026 (subject to material completion of customary onboarding procedures for members of the Board).</p>
<div class="lb-trans"><p>阿拉巴马州莫比尔 --（商业资讯）--TruBridge, Inc.（“TruBridge” 或 “公司”）（纳斯达克代码：TBRG），一家医疗解决方案公司，今天宣布已同意延长与 Pinetree Capital Ltd.和 L6 Holdings Inc.（统称 “Pinetree”）的合作协议。Pinetree 是公司的最大股东。根据合作协议，TruBridge 将于 2026 年 1 月 12 日（在完成董事会成员的常规入职程序后）任命 Damien Leonard 为董事会成员（“董事会”）。</p>
</div><p>Mr. Leonard is expected to join the Board as an independent director and will be appointed to the Compensation Committee. In connection with this addition, the Board is increasing in size from nine to ten directors, eight of whom are independent. In addition to David Dye’s previously announced intention to not stand for reelection at the 2026 Annual Meeting of Stockholders which will conclude his 24 years of service on the Board, two additional directors will not stand for reelection at the 2026 Annual Meeting pursuant to the Board’s ongoing refreshment efforts. Following the 2026 Annual Meeting, the Board’s size will be seven directors.</p>
<div class="lb-trans"><p>Leonard 先生预计将作为独立董事加入董事会，并将被任命为薪酬委员会成员。与此新增成员相关，董事会的规模将从九名董事增加到十名，其中八名为独立董事。除了 David Dye 之前宣布的在 2026 年股东年会上不再连任的意向（这将结束他在董事会的 24 年服务），还有两名额外董事将根据董事会的持续更新工作在 2026 年股东年会上不再连任。2026 年股东年会后，董事会的规模将为七名董事。</p>
</div><p>Mr. Leonard is the President of Pinetree Capital Ltd. He has over a decade of public markets investing experience in Canada, the United States, Europe and Australia, focusing on small-cap and special situation investing in enterprise software and technology businesses.</p>
<div class="lb-trans"><p>Leonard 先生是 Pinetree Capital Ltd.的总裁。他在加拿大、美国、欧洲和澳大利亚拥有超过十年的公共市场投资经验，专注于小型股和特殊情况投资，尤其是在企业软件和技术业务领域。</p>
</div><p>“We are pleased to welcome Damien to our Board,” said Glenn Tobin, chairman of the Board. “We believe Damien’s investor perspective as well as his finance, capital markets and capital allocation experience, will be of great value to our Board. Adding Damien continues the process of Board refreshment to support our operational effectiveness and long-term strategy.”</p>
<div class="lb-trans"><p>“我们很高兴欢迎 Damien 加入我们的董事会，” 董事会主席 Glenn Tobin 表示。“我们相信 Damien 的投资者视角以及他的金融、资本市场和资本配置经验，将对我们的董事会产生巨大价值。增加 Damien 继续推进董事会更新的进程，以支持我们的运营效率和长期战略。”</p>
</div><p>Pursuant to the cooperation agreement, one additional director will not stand for reelection at the 2027 Annual Meeting of Stockholders. Additionally, in connection with the cooperation agreement, Pinetree has agreed to customary standstill, voting and other provisions. Mr. Leonard will waive his director’s fees in connection with his service on the Board.</p>
<div class="lb-trans"><p>根据合作协议，另一名董事将在 2027 年股东年会上不再连任。此外，关于合作协议，Pinetree 已同意常规的停滞、投票和其他条款。Leonard 先生将放弃他在董事会服务期间的董事费用。</p>
</div><p>“We are pleased to reach a constructive agreement with Pinetree,” said Chris Fowler, chief executive officer of TruBridge. “TruBridge is building momentum, and these initiatives will further enhance our ability to execute our growth strategy with favorable results. We are confident Damien will be a valued colleague and member of our Board, and investor in the Company, as we continue to capitalize on the significant opportunities ahead to create sustainable value for all of our stockholders.”</p>
<div class="lb-trans"><p>“我们很高兴与 Pinetree 达成建设性协议，” TruBridge 首席执行官 Chris Fowler 表示。“TruBridge 正在积累势头，这些举措将进一步增强我们执行增长战略的能力，取得良好成果。我们相信 Damien 将成为我们董事会的宝贵同事和成员，以及公司的投资者，因为我们将继续利用前方显著的机会，为所有股东创造可持续价值。”</p>
</div><p>The full text of the cooperation agreement with Pinetree will be included as an exhibit to the Company’s Current Report on Form 8-K, which will be filed with the U.S. Securities and Exchange Commission.</p>
<div class="lb-trans"><p>与 Pinetree 的合作协议的完整文本将作为公司的当前报告的附件包含在 Form 8-K 中，该报告将提交给美国证券交易委员会。</p>
</div><p>BofA Securities, Inc. is serving as advisor to the Company in connection with the Company’s shareholder engagement, and Sullivan &amp; Cromwell LLP and Maynard Nexsen PC are serving as legal counsel.</p>
<div class="lb-trans"><p>BofA Securities, Inc.正在为公司提供股东参与方面的顾问服务，Sullivan &amp; Cromwell LLP 和 Maynard Nexsen PC 担任法律顾问。</p>
</div><p><strong>About TruBridge</strong></p>
<div class="lb-trans"><p><strong>关于 TruBridge</strong></p>
</div><p>TruBridge proudly supports rural and community healthcare providers in their efforts to stay strong, independent, and deeply rooted in the communities they serve. Backed by more than 45 years of healthcare experience and trusted by over 1,500 clients nationwide, TruBridge offers a mix of technology, services, and strategic expertise — including revenue cycle management (RCM), electronic health records (EHR) and analytics — all designed singularly for the realities of rural and community healthcare. With a steadfast commitment to keeping care local, TruBridge helps hospitals flourish as the economic heart of their communities, delivering high-quality, deeply personal care close to home.</p>
<div class="lb-trans"><p>TruBridge 自豪地支持农村和社区医疗提供者，帮助他们在努力保持强大、独立和深深扎根于服务的社区中。凭借超过 45 年的医疗经验和全国超过 1,500 个客户的信任，TruBridge 提供一系列技术、服务和战略专业知识——包括收入周期管理（RCM）、电子健康记录（EHR）和分析——所有这些都是专门为农村和社区医疗的现实而设计。TruBridge 坚定承诺保持本地护理，帮助医院作为其社区的经济核心蓬勃发展，提供高质量、深具个人化的本地护理。</p>
</div><p><strong>Forward-Looking Statements</strong></p>
<div class="lb-trans"><p><strong>前瞻性声明</strong></p>
</div><p><em>This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified generally by the use of forward-looking terminology and words such as “expects,” “anticipates,” “estimates,” “believes,” “predicts,” “intends,” “plans,” “potential,” “may,” “continue,” “should,” “will” and words of comparable meaning. Without limiting the generality of the preceding statement, all statements in this press release relating to the Company’s ability to finalize the appointment of Mr. Leonard to the Board, to execute on the Company’s strategy and to enhance value for the Company’s stockholders are forward-looking statements. We caution investors that any such forward-looking statements are only predictions and are not guarantees of future performance. Certain risks, uncertainties and other factors may cause actual results to differ materially from those projected in the forward-looking statements. Such factors include, with respect to finalizing the appointment of Mr. Leonard to the Board, the completion of the customary onboarding procedures and, with respect to the Company’s strategy and enhancing value, may include: saturation of our target market and hospital consolidations; unfavorable economic or market conditions that may cause a decline in spending for information technology and services; significant legislative and regulatory uncertainty in the healthcare industry; exposure to liability for failure to comply with regulatory requirements; transition to a subscription based recurring revenue model and modernization of our technology; competition with companies that have greater financial, technical and marketing resources than we have; potential future acquisitions that may be expensive, time consuming, and subject to other inherent risks; our ability to attract and retain qualified personnel in a global workforce; disruption from periodic restructuring of our sales force; slower than anticipated development of the market for Financial Health services; potential inability to properly manage growth in new markets we may enter; potential failure to effectively implement a new enterprise resource planning software solution; exposure to numerous and often conflicting laws, regulations, policies, standards or other requirements through our domestic and international business activities; potential litigation against us and investigations; our use of offshore third-party resources; competitive and litigation risk related to the use of artificial intelligence; potential failure to develop new products or enhance current products that keep pace with market demands; failure of our products to provide accurate and timely information for clinical decision-making; breaches of security and viruses in our systems resulting in customer claims against us and harm to our reputation; failure to maintain customer satisfaction through new product releases free of undetected errors or problems; failure to convince customers to migrate to current or future releases of our products; failure to maintain our margins and service rates; increase in the percentage of total revenues represented by service revenues, which have lower gross margins; exposure to liability in the event we provide inaccurate claims data to payors; exposure to liability claims arising out of the licensing of our software and provision of services; dependence on licenses of rights, products and services from third parties; failure to protect our intellectual property rights; exposure to significant license fees or damages for intellectual property infringement; interruptions in our power supply and/or telecommunications capabilities; potential inability to secure additional financing on favorable terms to meet our future capital needs; our substantial indebtedness, and our ability to incur additional indebtedness in the future; pressures on cash flow to service our outstanding debt; restrictive terms of our credit agreement on our current and future operations; changes in and interpretations of financial accounting matters that govern the measurement of our performance; significant charges to earnings if our goodwill or intangible assets become impaired; fluctuations in quarterly financial performance due to various factors; volatility in our stock price; failure to maintain effective internal control over financial reporting; inherent limitations in our internal control over financial reporting; vulnerability to significant damage from natural disasters; market risks related to interest rate changes; potential material adverse effects due to macroeconomic conditions; we do not anticipate paying dividends on our common stock; actions of activist stockholders against us; and other risk factors described from time to time in our public releases and reports filed with the Securities and Exchange Commission. We also caution investors that the forward-looking information described herein represents our outlook only as of this date, and we undertake no obligation to update or revise any forward-looking statements to reflect events or developments after the date of this press release.</em></p>
<div class="lb-trans"><p>本新闻稿包含根据 1995 年《私人证券诉讼改革法案》“安全港” 条款的前瞻性声明。这些前瞻性声明通常可以通过使用前瞻性术语和词汇来识别，例如 “预计”、“预期”、“估计”、“相信”、“预测”、“打算”、“计划”、“潜在”、“可能”、“继续”、“应该”、“将” 和具有类似含义的词。为了不限制前述声明的一般性，本新闻稿中与公司最终任命 Leonard 先生为董事会成员、执行公司战略以及提升公司股东价值相关的所有声明均为前瞻性声明。我们提醒投资者，任何此类前瞻性声明仅为预测，并不保证未来的表现。某些风险、不确定性和其他因素可能导致实际结果与前瞻性声明中预测的结果存在重大差异。这些因素包括，关于最终任命 Leonard 先生为董事会成员，完成常规的入职程序；关于公司战略和提升价值，可能包括：我们目标市场的饱和和医院整合；不利的经济或市场条件可能导致信息技术和服务支出的下降；医疗行业的重大立法和监管不确定性；因未能遵守监管要求而面临的责任风险；向基于订阅的经常性收入模式的过渡和技术现代化；与财务、技术和市场资源比我们更强大的公司的竞争；潜在的未来收购可能成本高昂、耗时，并面临其他固有风险；我们在全球劳动力中吸引和留住合格人员的能力；由于销售团队的定期重组而造成的干扰；金融健康服务市场的发展速度低于预期；我们可能进入的新市场中有效管理增长的潜在失败；有效实施新的企业资源规划软件解决方案的潜在失败；通过我们的国内和国际业务活动面临众多且常常相互矛盾的法律、法规、政策、标准或其他要求的风险；针对我们的潜在诉讼和调查；我们使用离岸第三方资源的风险；与使用人工智能相关的竞争和诉讼风险；未能开发新产品或提升当前产品以跟上市场需求的潜在失败；我们的产品未能提供准确和及时的信息以支持临床决策；系统中的安全漏洞和病毒导致客户对我们的索赔和声誉受损；未能通过新产品发布保持客户满意度，且未发现错误或问题；未能说服客户迁移到当前或未来版本的产品；未能维持我们的利润率和服务费率；服务收入在总收入中所占比例增加，而服务收入的毛利率较低；在我们向支付方提供不准确的索赔数据时面临的责任风险；因软件许可和服务提供而产生的责任索赔风险；对第三方的权利、产品和服务的许可依赖；未能保护我们的知识产权；因知识产权侵权而面临的重大许可费用或损害赔偿；电力供应和/或电信能力中断的风险；在有利条件下无法获得额外融资以满足未来资本需求的潜在风险；我们巨额的债务，以及我们未来承担额外债务的能力；服务我们未偿债务的现金流压力；对我们当前和未来运营的信贷协议的限制条款；影响我们业绩测量的财务会计事项的变化和解释；如果我们的商誉或无形资产减值，将对收益产生重大影响；由于各种因素导致的季度财务表现波动；我们股票价格的波动；未能保持有效的财务报告内部控制；我们财务报告内部控制的固有限制；自然灾害造成的重大损害的脆弱性；与利率变化相关的市场风险；由于宏观经济条件可能导致的潜在重大不利影响；我们不预期向普通股支付股息；激进股东对我们的行动；以及不时在我们向证券交易委员会提交的公共发布和报告中描述的其他风险因素。我们还提醒投资者，此处描述的前瞻性信息仅代表我们截至本日期的展望，我们不承担更新或修订任何前瞻性声明以反映本新闻稿日期之后的事件或发展的义务。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1hY3FyOCZzdHk9MjAyNjAxMDczNjQ0MDJyMQ" alt="" original-src="https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20260107364402r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en"/></p>
<p>View source version on businesswire.com: https://www.businesswire.com/news/home/20260107364402/en/</p>
<div class="lb-trans"><p>在 businesswire.com 查看源版本：https://www.businesswire.com/news/home/20260107364402/en/</p>
</div><p>TruBridge Media</p>
<div class="lb-trans"><p>TruBridge Media</p>
</div><p>media@trubridge.com</p>
<div class="lb-trans"><p>media@trubridge.com</p>
</div><p>Source: TruBridge, Inc.</p>
<div class="lb-trans"><p>来源：TruBridge, Inc.</p>
</div>

TruBridge 宣布与 Pinetree Capital 延长合作协议 | TBRG 股票新闻